Latest Insider Transactions at Metacrine, Inc. (MTCR)
This section provides a real-time view of insider transactions for Metacrine, Inc. (MTCR). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Metacrine, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Metacrine, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 23
2023
|
Preston Klassen Director |
SELL
Grant, award, or other acquisition
|
Direct |
842,211
-37.83%
|
$0
$0.47 P/Share
|
|
Jan 26
2023
|
Preston Klassen Director |
SELL
Open market or private sale
|
Direct |
380,605
-41.26%
|
$0
$0.41 P/Share
|
|
Jan 26
2023
|
Michael York Chief Business Officer |
SELL
Open market or private sale
|
Direct |
107,054
-50.84%
|
$0
$0.41 P/Share
|
|
Dec 21
2022
|
Braden Michael Leonard > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
120,099
+1.91%
|
$0
$0.4 P/Share
|
|
Dec 20
2022
|
Braden Michael Leonard > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
50,122
+0.82%
|
$0
$0.38 P/Share
|
|
Dec 19
2022
|
Braden Michael Leonard > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
101,384
+1.66%
|
$0
$0.4 P/Share
|
|
Nov 09
2022
|
Braden Michael Leonard > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
39,816
+0.67%
|
$0
$0.39 P/Share
|
|
Nov 08
2022
|
Braden Michael Leonard > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
500
+0.01%
|
$0
$0.4 P/Share
|
|
Nov 07
2022
|
Braden Michael Leonard > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
123,954
+2.08%
|
$0
$0.42 P/Share
|
|
Oct 28
2022
|
Braden Michael Leonard > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
45,022
+0.78%
|
$0
$0.4 P/Share
|
|
Oct 27
2022
|
Braden Michael Leonard > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
767,507
+11.9%
|
$0
$0.39 P/Share
|
|
Oct 26
2022
|
Braden Michael Leonard > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
588,533
+10.7%
|
$0
$0.35 P/Share
|
|
Oct 25
2022
|
Braden Michael Leonard > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
499,279
+10.35%
|
$0
$0.35 P/Share
|
|
Oct 24
2022
|
Braden Michael Leonard > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
174,354
+4.36%
|
$0
$0.34 P/Share
|
|
Apr 19
2022
|
Preston Klassen Director |
SELL
Open market or private sale
|
Direct |
44,748
-2.32%
|
$0
$0.51 P/Share
|
|
Apr 14
2022
|
Preston Klassen Director |
BUY
Grant, award, or other acquisition
|
Direct |
104,500
+9.75%
|
-
|
|
Feb 27
2022
|
Michael York Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
210,553
+50.0%
|
-
|
|
Feb 27
2022
|
Preston Klassen Director |
BUY
Grant, award, or other acquisition
|
Direct |
842,211
+49.4%
|
-
|
|
Dec 22
2021
|
New Enterprise Associates 16, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
459,700
-7.9%
|
$0
$0.96 P/Share
|
|
Dec 22
2021
|
Forest Baskett > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
459,700
-7.9%
|
$0
$0.96 P/Share
|
|
Dec 22
2021
|
Ali Behbahani > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
459,700
-7.9%
|
$0
$0.96 P/Share
|
|
Dec 22
2021
|
Carmen Chang > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
459,700
-7.9%
|
$0
$0.96 P/Share
|
|
Dec 22
2021
|
Anthony A. Florence Jr. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
459,700
-7.9%
|
$0
$0.96 P/Share
|
|
Dec 22
2021
|
Mohamad Makhzoumi > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
459,700
-7.9%
|
$0
$0.96 P/Share
|
|
Dec 22
2021
|
Scott D Sandell > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
459,700
-7.9%
|
$0
$0.96 P/Share
|
|
Dec 22
2021
|
Peter W. Sonsini > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
459,700
-7.9%
|
$0
$0.96 P/Share
|
|
Dec 22
2021
|
Paul Edward Walker > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
459,700
-7.9%
|
$0
$0.96 P/Share
|
|
Dec 10
2021
|
New Enterprise Associates 16, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
37,570
-1.23%
|
$37,570
$1.32 P/Share
|
|
Dec 10
2021
|
Forest Baskett > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
37,570
-1.23%
|
$37,570
$1.32 P/Share
|
|
Dec 10
2021
|
Ali Behbahani > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
37,570
-1.23%
|
$37,570
$1.32 P/Share
|
|
Dec 10
2021
|
Carmen Chang > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
37,570
-1.23%
|
$37,570
$1.32 P/Share
|
|
Dec 10
2021
|
Anthony A. Florence Jr. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
37,570
-1.23%
|
$37,570
$1.32 P/Share
|
|
Dec 10
2021
|
Mohamad Makhzoumi > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
37,570
-1.23%
|
$37,570
$1.32 P/Share
|
|
Dec 10
2021
|
Scott D Sandell > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
37,570
-1.23%
|
$37,570
$1.32 P/Share
|
|
Dec 10
2021
|
Peter W. Sonsini > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
37,570
-1.23%
|
$37,570
$1.32 P/Share
|
|
Dec 10
2021
|
Paul Edward Walker > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
37,570
-1.23%
|
$37,570
$1.32 P/Share
|
|
Oct 25
2021
|
Ven Bio Global Strategic Fund, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
540,667
-18.12%
|
$540,667
$1.49 P/Share
|
|
Oct 22
2021
|
Ven Bio Global Strategic Fund, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
75,035
-2.45%
|
$75,035
$1.64 P/Share
|
|
May 20
2021
|
Hubert C Chen Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
3,289
+50.0%
|
$9,867
$3.6 P/Share
|
|
May 20
2021
|
Preston Klassen Director |
BUY
Open market or private purchase
|
Direct |
20,547
+50.0%
|
$61,641
$3.64 P/Share
|
|
May 05
2021
|
Trisha Millican Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
759
+1.78%
|
-
|
|
May 05
2021
|
Catherine Chai Zon Lee EVP, Gen. Counsel & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
3,846
+50.0%
|
-
|